Burden & Treatment Considerations For Agitation Associated With Alzheimer’s Dementia
Burden & Treatment Considerations For Agitation Associated With Alzheimer’s Dementia
Speaker W. Clay Jackson, MD, DipTh is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Speaker Bryan Archuleta, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)